Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
JCO Precision Oncology
|
June 30, 2022
Homologous Recombination Deficiency in Pancreatic Cancer: Poly (ADP-ribose) Polymerase Inhibition, Checkpoint Inhibition, or a Combination of Both?
Fergus Keane, Wungki Park, Eileen M O'Reilly
JAMA
|
April 12, 2022
Incidence of Pancreatic Cancer by Age and Sex in the US From 2000 to 2018
Fergus Keane, Mengmeng Du, Eileen M O'Reilly
Case Reports in Oncology
|
March 29, 2021
Synchronous Melanoma and Pancreas Malignancies Leading to a Discovery of a CDKN2A Mutation in a Patient with No Known Family History
Mary O'Reilly, Fergus Keane, Ray Mc Dermott
Clinical Advances in Hematology & Oncology : H&O
|
May 13, 2024
Immune checkpoint inhibitor therapy in locally advanced MSI GI malignancies
Emily C Harrold, Fergus Keane, Andrea Cercek
Diagnostics (Basel, Switzerland)
|
June 10, 2023
Clinical Utility of
Darren Cowzer, Fergus Keane, Geoffrey Y Ku
BMJ Case Reports
|
September 10, 2016
Aspirin unmasking acquired haemophilia A in a patient with prostate cancer
Julie Omolola Okiro, Amjad Zaman Khan, Fergus Keane, et al.
Cancers
|
June 10, 2023
Pancreatic Cancer:
Fergus Keane, Catherine A O'Connor, Wungki Park, et al.
Endocrinology, Diabetes & Metabolism Case Reports
|
June 11, 2016
Gonadotropin-releasing hormone agonist-induced pituitary apoplexy
Fergus Keane, Aoife M Egan, Patrick Navin, et al.
Oncology Research and Treatment
|
March 7, 2023
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation
Bruno Almeida Costa, Paulino Tallón de Lara, Wungki Park, et al.
NPJ Precision Oncology
|
April 22, 2023
Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: opportunity and challenge
Fergus Keane, Raazi Bajwa, Pier Selenica, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
JCO Precision Oncology
|
June 30, 2022
Homologous Recombination Deficiency in Pancreatic Cancer: Poly (ADP-ribose) Polymerase Inhibition, Checkpoint Inhibition, or a Combination of Both?
Fergus Keane, Wungki Park, Eileen M O'Reilly
JAMA
|
April 12, 2022
Incidence of Pancreatic Cancer by Age and Sex in the US From 2000 to 2018
Fergus Keane, Mengmeng Du, Eileen M O'Reilly
Case Reports in Oncology
|
March 29, 2021
Synchronous Melanoma and Pancreas Malignancies Leading to a Discovery of a CDKN2A Mutation in a Patient with No Known Family History
Mary O'Reilly, Fergus Keane, Ray Mc Dermott
Clinical Advances in Hematology & Oncology : H&O
|
May 13, 2024
Immune checkpoint inhibitor therapy in locally advanced MSI GI malignancies
Emily C Harrold, Fergus Keane, Andrea Cercek
Diagnostics (Basel, Switzerland)
|
June 10, 2023
Clinical Utility of
Darren Cowzer, Fergus Keane, Geoffrey Y Ku
BMJ Case Reports
|
September 10, 2016
Aspirin unmasking acquired haemophilia A in a patient with prostate cancer
Julie Omolola Okiro, Amjad Zaman Khan, Fergus Keane, et al.
Cancers
|
June 10, 2023
Pancreatic Cancer:
Fergus Keane, Catherine A O'Connor, Wungki Park, et al.
Endocrinology, Diabetes & Metabolism Case Reports
|
June 11, 2016
Gonadotropin-releasing hormone agonist-induced pituitary apoplexy
Fergus Keane, Aoife M Egan, Patrick Navin, et al.
Oncology Research and Treatment
|
March 7, 2023
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation
Bruno Almeida Costa, Paulino Tallón de Lara, Wungki Park, et al.
NPJ Precision Oncology
|
April 22, 2023
Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: opportunity and challenge
Fergus Keane, Raazi Bajwa, Pier Selenica, et al.
Page
of 4